Technological Innovations and their Impact on Pharmaceutical Industry: An Empirical Study of Medical Representatives

Authors

  • KOMAL CHANDRA Assistant Professor,Department of Pharmacy , Graphic Era Hill University, Dehradun Uttarakhand India 248002 Author

DOI:

https://doi.org/10.61841/pd0xf648

Keywords:

Pharmaceutical Industry, Research, and development, Patent Laws, Patent reforms

Abstract

 The pharmaceutical industry's unique company model and commercial operations have a notable impact on the process of delivering new drugs to patients, even though they are not widely comprehended outside of the industry. The likelihood of a new drug succeeding could be higher, and the process is very time-consuming, costly, and hazardous. After implementing international patent rules on January 1st, 2005, the Indian Pharmaceutical Industry saw a tremendous shift. India's indigenous pharmaceutical businesses have seen massive growth in R & D investment to remain competitive in the global pharmaceutical industry. India has very well researchers, a well-established computer industry, and technology for producing bulk pharmaceuticals and formulations, despite the country's limited pharmaceutical market and lack of financing for drug development initiatives. Following a discussion of the company's commercial realities and restrictions, along with its current issues, there follows an examination of some of the expected future commercial and technological advances in the company. 

Downloads

Download data is not yet available.

References

1. Tyagi, S., Mahajan,V., & Nauriyal,D,K. (2014). Innovations In Indian Drug And

Pharmaceutical Industry: Have They Impacted Exports? Vol 19(4). Pp- 243-252.

2. Achilladelis, B., & Antonakis, N. (2001). The Dynamics Of Technological Innovation:

The Case Of The Pharmaceutical Industry. Research Policy, 30(4), 535–588.

3. Staropoli, C. (1998). Cooperation In R&D In The Pharmaceutical Industry — The

Network As An Organizational Innovation Governing Technological Innovation.

Technovation, 18(1), 13–23.

4. De Carolis, D. M. (2003). Competencies And Imitability In The Pharmaceutical

Industry: An Analysis Of Their Relationship With Firm Performance. Journal Of

Management, 29(1), 27–50.

5. Becker, M. C., & Lillemark, M. (2006). Marketing/R&D Integration in The

Pharmaceutical Industry. Research Policy, 35(1), 105–120.

6. Jena, S., Katual, M,K., Jena, S., & Harikumar, S,L. (2017). Innovation In Pharma

Sector: The Impact of IPR (Product Patent) In Indian Scenario: An Overview. 4 (3). Pp-

2368-2372.

7. Shah,G., Kamble,P., Shinde,R., & Ghatge, K. (2014). Advances In Technology Transfer

for The Pharmaceutical Industries: An Overview. 7(6). 719-726.

8. Cardinal, L. B. (2001). Technological Innovation In The Pharmaceutical Industry: The

Use Of Organizational Control In Managing Research And Development. Organization

Science, 12(1), 19–36.

9. Janodia, M, D., Rao, V., Pandey, S., Sreedhar, D., Ligade, S,V., Udupa, N. (2009).

Impact Of Patents On Indian Pharma Industry’s Growth And Competency: A Viewpoint

Of Pharmaceutical Companies In India. 14(5). Pp- 432-436.

10. Abrol,D., Prajapti, P., & Singh, N. (2011). Globalization Of The Indian Pharmaceutical

Industry: Implications For Innovation. 3(2). 327-365.

11. Chaturvedi, K., & Chataway, J. (2006). Strategic Integration of Knowledge In Indian

Pharmaceutical Firms: Creating Competencies For Innovation. International Journal of

Business Innovation And Research, 1(1/2), 27-50.

12. Schuhmacher, A., Germann, P.-G., Trill, H., & Gassmann, O. (2013). Models For Open

Innovation in The Pharmaceutical Industry. Drug Discovery Today, 18(23-24), 1133–

1137.

Downloads

Published

28.02.2021

How to Cite

CHANDRA, K. (2021). Technological Innovations and their Impact on Pharmaceutical Industry: An Empirical Study of Medical Representatives. International Journal of Psychosocial Rehabilitation, 25(1), 740-747. https://doi.org/10.61841/pd0xf648